TCA
CL icon

Transcend Capital Advisors’s Colgate-Palmolive CL Stock Holding History

Transcend Capital Advisors’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$987K Buy
11,583
+1,767
+18% +$157K 0.08% 232
2025
Q4 		$776K Sell
9,816
-440
-4% -$34.5K 0.06% 279
2025
Q3 		$820K Sell
10,256
-325
-3% -$27.7K 0.06% 285
2025
Q2 		$962K Sell
10,581
-7,924
-43% -$723K 0.07% 241
2025
Q1 		$1.73M Buy
18,505
+477
+3% +$42.7K 0.12% 178
2024
Q4 		$1.64M Sell
18,028
-421
-2% -$40.2K 0.12% 179
2024
Q3 		$1.92M Sell
18,449
-539
-3% -$54.9K 0.13% 176
2024
Q2 		$1.84M Buy
18,988
+26
+0.1% +$2.4K 0.13% 165
2024
Q1 		$1.71M Sell
18,962
-72
-0.4% -$6.1K 0.14% 165
2023
Q4 		$1.52M Buy
19,034
+3
+0% +$226 0.13% 166
2023
Q3 		$1.35M Sell
19,031
-2,356
-11% -$176K 0.13% 164
2023
Q2 		$1.65M Sell
21,387
-208
-1% -$16.1K 0.16% 150
2023
Q1 		$1.62M Sell
21,595
-748
-3% -$55.6K 0.17% 140
2022
Q4 		$1.76M Sell
22,343
-506
-2% -$37.9K 0.19% 128
2022
Q3 		$1.6M Buy
22,849
+1,282
+6% +$101K 0.18% 137
2022
Q2 		$1.73M Buy
21,567
+1,208
+6% +$94.5K 0.18% 135
2022
Q1 		$1.54M Sell
20,359
-60
-0.3% -$4.75K 0.14% 166
2021
Q4 		$1.74M Sell
20,419
-29
-0.1% -$2.27K 0.15% 154
2021
Q3 		$1.56M Sell
20,448
-1,001
-5% -$79.5K 0.14% 160
2021
Q2 		$1.74M Buy
21,449
+1,422
+7% +$116K 0.25% 100
2021
Q1 		$1.58M Sell
20,027
-294
-1% -$23K 0.19% 124
2020
Q4 		$1.74M Buy
20,321
+8,530
+72% +$705K 0.23% 109
2020
Q3 		$910K Buy
11,791
+771
+7% +$58.8K 0.17% 123
2020
Q2 		$807K Buy
11,020
+5,342
+94% +$379K 0.26% 84
2020
Q1 		$381K Buy
+5,678
New +$400K 0.11% 159

Other funds holding CL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Transcend Capital Advisors's CL Position: Q1 2026 in Review

Transcend Capital Advisors increased its Colgate-Palmolive (CL) stake by 18% in Q1 2026, buying an estimated $157K and bringing the position to 11,583 shares worth $987K. The position accounts for 0.08% of the portfolio, ranked #232.

Transcend Capital Advisors first reported a position in CL in Q1 2020 and has held it in 25 quarters since. The position peaked at $1.92M in Q3 2024. 1,946 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Transcend Capital Advisors held 11,583 shares of Colgate-Palmolive worth $987K as of Q1 2026.
  • Transcend Capital Advisors bought 1,767 Colgate-Palmolive shares in Q1 2026, an estimated $157K.
  • Colgate-Palmolive made up 0.08% of Transcend Capital Advisors's portfolio in Q1 2026, its #232 holding.
  • Transcend Capital Advisors first reported a position in Colgate-Palmolive in Q1 2020 and has held it in 25 quarters since.
  • Transcend Capital Advisors's Colgate-Palmolive position peaked at $1.92M in Q3 2024.
  • 1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Transcend Capital Advisors's 13F filing for Q1 2026, filed 13 May 2026.